Agonist or levodopa for Parkinson disease?: ultimately, it doesn't matter; neither is good enough

Neurology. 2008 Aug 12;71(7):470-1. doi: 10.1212/01.wnl.0000324860.70391.25.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiparkinson Agents / therapeutic use*
  • Clinical Trials as Topic
  • Humans
  • Levodopa / therapeutic use*
  • Parkinson Disease / drug therapy*

Substances

  • Antiparkinson Agents
  • Levodopa